Trending Stock News

Lenox Wealth Management Has Decreased Position in Procter & Gamble Co (PG) by $679,952 as Stock Declined; Salem Capital Management Has Cut Its Position in Abbott Laboratories (ABT) by $303,468 as Share Value Rose

Abbott Laboratories (NYSE:ABT) Logo

Salem Capital Management Inc decreased its stake in Abbott Laboratories (ABT) by 17.08% based on its latest 2017Q4 regulatory filing with the SEC. Salem Capital Management Inc sold 5,324 shares as the company’s stock rose 5.88% while stock markets declined. The institutional investor held 25,845 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $1.48 million, down from 31,169 at the end of the previous reported quarter. Salem Capital Management Inc who had been investing in Abbott Laboratories for a number of months, seems to be less bullish one the $106.54B market cap company. The stock increased 0.38% or $0.23 during the last trading session, reaching $60.77. About 3.59M shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since May 17, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Lenox Wealth Management Inc decreased its stake in Procter & Gamble Co (PG) by 1.55% based on its latest 2017Q4 regulatory filing with the SEC. Lenox Wealth Management Inc sold 7,472 shares as the company’s stock declined 15.56% with the market. The institutional investor held 475,964 shares of the package goods and cosmetics company at the end of 2017Q4, valued at $43.73M, down from 483,436 at the end of the previous reported quarter. Lenox Wealth Management Inc who had been investing in Procter & Gamble Co for a number of months, seems to be less bullish one the $184.90B market cap company. The stock increased 0.80% or $0.58 during the last trading session, reaching $73.53. About 8.32 million shares traded. The Procter & Gamble Company (NYSE:PG) has declined 14.03% since May 17, 2017 and is downtrending. It has underperformed by 25.58% the S&P500.

Since February 15, 2018, it had 0 insider purchases, and 6 selling transactions for $6.67 million activity. $739,189 worth of The Procter & Gamble Company (NYSE:PG) was sold by Posada Juan Fernando. 1,313 shares valued at $103,190 were sold by Fish Kathleen B on Wednesday, February 28. 2,075 The Procter & Gamble Company (NYSE:PG) shares with value of $149,130 were sold by Bishop Steven D. 8,502 shares valued at $668,179 were sold by Pritchard Marc S. on Thursday, February 15.

Analysts await The Procter & Gamble Company (NYSE:PG) to report earnings on July, 26. They expect $0.91 earnings per share, up 7.06% or $0.06 from last year’s $0.85 per share. PG’s profit will be $2.29B for 20.20 P/E if the $0.91 EPS becomes a reality. After $1.00 actual earnings per share reported by The Procter & Gamble Company for the previous quarter, Wall Street now forecasts -9.00% negative EPS growth.

More notable recent The Procter & Gamble Company (NYSE:PG) news were published by: Seekingalpha.com which released: “Retirement Strategy: I Am Done Being Wrong About This Market” on May 16, 2018, also 247Wallst.com with their article: “Dow’s Worst Performing Stock Still Procter & Gamble” published on May 05, 2018, Seekingalpha.com published: “Trading Mistake 6: Lack Of Portfolio Leverage” on May 17, 2018. More interesting news about The Procter & Gamble Company (NYSE:PG) were released by: Fool.com and their article: “2 Reasons To Not Buy Proctor & Gamble Stock” published on May 15, 2018 as well as 247Wallst.com‘s news article titled: “Procter & Gamble Settling In as Worst-Performing Dow Stock of 2018” with publication date: April 28, 2018.

Lenox Wealth Management Inc, which manages about $693.17M and $329.21M US Long portfolio, upped its stake in Ishares Gold Trust (IAU) by 310,207 shares to 501,392 shares, valued at $6.27 million in 2017Q4, according to the filing. It also increased its holding in Spdr S&P Dividend Etf (SDY) by 6,575 shares in the quarter, for a total of 27,636 shares, and has risen its stake in Reckitt Benckiser Group Plc (RBGLY).

Among 25 analysts covering Proctor & Gamble (NYSE:PG), 10 have Buy rating, 1 Sell and 14 Hold. Therefore 40% are positive. Proctor & Gamble had 89 analyst reports since August 4, 2015 according to SRatingsIntel. SunTrust maintained The Procter & Gamble Company (NYSE:PG) rating on Thursday, October 5. SunTrust has “Hold” rating and $85.0 target. As per Tuesday, January 19, the company rating was upgraded by Stifel Nicolaus. Deutsche Bank downgraded the shares of PG in report on Friday, April 20 to “Hold” rating. RBC Capital Markets maintained it with “Sector Perform” rating and $76 target in Tuesday, October 27 report. The stock of The Procter & Gamble Company (NYSE:PG) has “Buy” rating given on Tuesday, October 17 by Jefferies. On Friday, August 26 the stock rating was upgraded by Johnson Rice to “Buy”. RBC Capital Markets maintained it with “Hold” rating and $80.0 target in Tuesday, September 5 report. As per Tuesday, October 24, the company rating was maintained by Morgan Stanley. The stock of The Procter & Gamble Company (NYSE:PG) has “Neutral” rating given on Wednesday, January 6 by Atlantic Securities. The company was upgraded on Tuesday, September 8 by Suntrust Robinson.

Investors sentiment increased to 0.89 in 2017 Q4. Its up 0.07, from 0.82 in 2017Q3. It increased, as 64 investors sold PG shares while 740 reduced holdings. 118 funds opened positions while 594 raised stakes. 1.47 billion shares or 1.61% less from 1.50 billion shares in 2017Q3 were reported. North Star Asset Mngmt accumulated 20,652 shares or 0.17% of the stock. State Common Retirement Fund stated it has 7.23M shares. 424,103 were reported by Putnam Invs Ltd Liability Co. Arizona State Retirement System stated it has 0.6% in The Procter & Gamble Company (NYSE:PG). Gilman Hill Asset Mgmt Limited Liability Company holds 9,866 shares. Pathstone Family Office Lc reported 417 shares stake. Bankshares Of Stockton owns 6,431 shares for 0.24% of their portfolio. Moreover, Freestone Holdg Ltd Liability has 0.35% invested in The Procter & Gamble Company (NYSE:PG). Pinnacle Advisory Gp invested 0.05% of its portfolio in The Procter & Gamble Company (NYSE:PG). Riverpoint Management Ltd Liability Corporation holds 1.75% or 314,090 shares in its portfolio. Maple Capital Mngmt holds 33,987 shares or 0.8% of its portfolio. Braun Stacey Associate Inc holds 1.11% or 180,566 shares. Wms Ltd holds 0.68% in The Procter & Gamble Company (NYSE:PG) or 65,346 shares. Shamrock Asset Limited Liability Com holds 0.36% of its portfolio in The Procter & Gamble Company (NYSE:PG) for 6,688 shares. Hl Financial Lc, Kentucky-based fund reported 697,281 shares.

Since December 14, 2017, it had 1 buying transaction, and 20 selling transactions for $23.69 million activity. Salvadori Daniel Gesua Sive sold $53,369 worth of stock or 905 shares. $58,635 worth of Abbott Laboratories (NYSE:ABT) shares were sold by Watkin Jared. The insider Fussell Stephen R sold $3.36M. Shares for $96,728 were sold by BIRD ROGER. $2.69M worth of Abbott Laboratories (NYSE:ABT) was sold by Ford Robert B. 2,150 shares were sold by Bracken Sharon J, worth $125,909.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on July, 19. They expect $0.71 EPS, up 14.52% or $0.09 from last year’s $0.62 per share. ABT’s profit will be $1.24B for 21.40 P/E if the $0.71 EPS becomes a reality. After $0.59 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 20.34% EPS growth.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. The company was maintained on Thursday, January 26 by RBC Capital Markets. As per Friday, September 1, the company rating was maintained by RBC Capital Markets. The stock of Abbott Laboratories (NYSE:ABT) earned “Buy” rating by Stifel Nicolaus on Thursday, July 23. The company was maintained on Thursday, January 25 by Wells Fargo. The firm has “Buy” rating by Jefferies given on Tuesday, September 5. Edward Jones upgraded the stock to “Buy” rating in Tuesday, June 21 report. The rating was maintained by Jefferies on Tuesday, September 13 with “Buy”. As per Wednesday, June 21, the company rating was reinitiated by BTIG Research. RBC Capital Markets maintained Abbott Laboratories (NYSE:ABT) on Wednesday, March 1 with “Outperform” rating. The firm has “Buy” rating by Stifel Nicolaus given on Wednesday, April 19.

Investors sentiment increased to 0.91 in 2017 Q4. Its up 0.04, from 0.87 in 2017Q3. It is positive, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Virtus Advisers stated it has 0.2% in Abbott Laboratories (NYSE:ABT). Nelson Roberts Inv Advisors Ltd Liability reported 0.13% of its portfolio in Abbott Laboratories (NYSE:ABT). 208,025 were reported by Dillon & Associates. Bridges Counsel owns 37,142 shares for 1.17% of their portfolio. Indiana Trust Mgmt invested 0.5% in Abbott Laboratories (NYSE:ABT). Boltwood Cap Management has 0.92% invested in Abbott Laboratories (NYSE:ABT) for 26,350 shares. Oakbrook Investments Limited Liability Co stated it has 84,721 shares. Country Club Company Na accumulated 12,897 shares. First Citizens Financial Bank Commerce holds 0.62% or 81,266 shares. 34,272 were reported by Cubic Asset Management Limited Liability Corp. Bradley Foster Sargent Incorporated Ct has invested 0.87% in Abbott Laboratories (NYSE:ABT). Choate Investment Advsr invested 0.34% of its portfolio in Abbott Laboratories (NYSE:ABT). Wesbanco Commercial Bank Inc has 0.21% invested in Abbott Laboratories (NYSE:ABT) for 53,915 shares. Fin Prtnrs Capital Mngmt Ltd holds 5,930 shares. Svcs Automobile Association, Texas-based fund reported 1.18M shares.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *